Amended Current Report Filing (8-k/a)
August 03 2020 - 5:00PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
Amendment
No. 1
CURRENT
REPORT
PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (date of earliest event reported): May 18, 2020
HealthLynked
Corp.
(Exact Name of Registrant as Specified in its Charter)
Nevada
|
|
47-1634127
|
(State
of Incorporation)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
1726
Medical Blvd., Suite 101, Naples, Florida
|
|
34110
|
(Address
of Principal Executive Offices)
|
|
(ZIP
Code)
|
(239)
513-1992
(Registrant’s
Telephone Number, Including Area Code)
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant
to Section 12(b) of the Act: None.
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☒
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
EXPLANATORY
NOTE
This Current Report on Form 8-K/A (this “Amendment
No. 1”) is being filed to amend and supplement “Item 9.01 – Financial Statements and Exhibits,” included
in the initial report on Form 8-K filed by HealthLynked Corp. (the “Corporation”) on May 20, 2020 (the “Initial
Filing”), to include the required audited and unaudited consolidated financial statements of Cura Health Management LLC
and ACO Health Partners, LLC (collectively, the “Acquired Subsidiaries”), pursuant to Rule 3-05(b) of Regulation
S-X, and the unaudited pro forma consolidated financial statements for the consolidated Corporation and Acquired Subsidiaries pursuant
to Article 11 of Regulation S-X. The required audited and unaudited consolidated financial statements and unaudited pro forma consolidated
financial statements are filed as exhibits to this report under Item 9.01.
The
information previously reported on the Initial Filing is incorporated by reference into this Amendment No. 1. The other items
to the Initial Filing further remain unchanged and are not amended hereby.
Item
9.01. Financial Statements and Exhibits.
(a)
Financial Statements of Businesses Acquired. The audited consolidated financial statements of the Acquired Subsidiaries
for the years ended December 31, 2019 and 2018, and the unaudited condensed consolidated financial statements for the three months
ended March 31, 2020 and 2019, including the notes to such financial statements and the report of independent auditors thereon,
are filed as Exhibit 99.1 to this Current Report on Form 8-K/A and incorporated into this Item 9.01(a) by reference.
(b)
Pro Forma Financial Information. The pro forma financial information required by this item is filed as Exhibit 99.2 to
this Form 8-K/A.
(d) Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTHLYNKED
CORP.
|
|
|
Dated:
August 3, 2020
|
/s/
George O’Leary
|
|
George
O’Leary
|
|
Chief
Financial Officer
|
2
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Aug 2024 to Sep 2024
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Sep 2023 to Sep 2024